|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 0.5000 CAD | -.--% |
|
-1.96% | +9.89% |
| 03/06 | PharmaCorp Rx Initiated at Outperform, $0.70 Price Target at Raymond James | MT |
| 01/06 | Earnings Flash (PCRX.V) PharmaCorp Reports Q1 Revenue $7.2M, Up 79.4% YoY | MT |
Main competitors
| Consensus | Analysts' target price evolution (4 months) | Analysts' recommendations evolution (4 months) | Financial estimates divergence | Analysts' Target price divergence | Average Target P. | Objective/dr gap | Nbr of analysts | ||
|---|---|---|---|---|---|---|---|---|---|
 | 0.6667 | +33.33% | 3 | ||||||
| 62.04 | +118.1% | 16 | ||||||
| 4.7 | +76.14% | 16 | ||||||
| 2,979 | +28.43% | 10 | ||||||
| 338.5 | +46% | 8 | ||||||
| 125.87 | +34.34% | 9 | ||||||
| 33.72 | +77.17% | 12 | ||||||
| 47 | +11.56% | 6 | ||||||
| 24.49 | +51.63% | 8 | ||||||
| - | - | 1,415 | +215.14% | 1 | ||||
| 37.19 | +12.59% | 8 | ||||||
| 79.67 | +14.38% | 9 | ||||||
| 1,168.71 | +43.13% | 7 | ||||||
| 58.31 | +32.71% | 7 | ||||||
| 14.86 | +47.59% | 5 | ||||||
| - | 90 | +20% | 2 | |||||
| Average | 404.98 | +53.89% | 8 | ||||||
| Weighted average by Cap. | 487 | +72.28% | 11 |
- Stock Market
- Stocks
- PCRX Stock
- Sector PharmaCorp Rx Inc.
- Sector consensus
Select your edition
All financial news and data tailored to specific country editions
